Functional analysis through gain- or loss-of-function studies showed that Rpb3-overexpression enhanced HCC cell proliferation, migration and in vivo tumor growth, whereas Rpb3-knockdown using shRNA inhibited HCC cell proliferation, migration and in vivo tumor growth. The gene discussed is POLR2C; the disease is hepatocellular carcinoma.